Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 02, 2024 10:47pm
RE:RE:RE:RE:RE:Early warrant exercise
I wouldn't get too hung up on these warrants. The math makes sense to me. Let's put it this way ... If you could get 100% (or a high percentage) of the warrants exercised in this 1
...more
(218)
•••
baggerx99
X
View Profile
View Bullboard History
Comment by
baggerx99
on Jan 01, 2024 11:35am
RE:RE:RE:RE:RE:Early warrant exercise
Can only assume the session with Allele Capital on Jan 18 will spark interest from warrant holders and maybe even news on the IDB front which is expected Q1. Would there be some motivation to
...more
(254)
•••
matt2018
X
View Profile
View Bullboard History
Comment by
matt2018
on Dec 31, 2023 3:51pm
RE:RE:RE:RE:Early warrant exercise
if the holders of these warrants want to dump them after acquiring them for a buck, thats fine. The bigger issue is why the rush to get this potential $6.5M? Whats odd is back oin Dec 12th they
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Dec 30, 2023 10:14am
RE:RE:RE:Early warrant exercise
there has to be some catalyst announcement, i think it has to be the start of P2 in dans "conversation with antibe" speach on jan/18. because the regular blah blah blah speach will not get
...more
(379)
•••
Benedictus
X
View Profile
View Bullboard History
Comment by
Benedictus
on Dec 29, 2023 11:46pm
RE:RE:Early warrant exercise
Right, just guessing here, but it seems likely they would want to announce the start of p2 prior to this "incentive" window opening up and then bank on that confirmation driving the sp
...more
(2879)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Dec 29, 2023 10:25am
Antibe Announces Early Warrant Exercise Incentive Program
December 29, 2023 07:00 AM Eastern Standard Time TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to
...more
(254)
•••
matt2018
X
View Profile
View Bullboard History
Comment by
matt2018
on Dec 29, 2023 10:21am
RE:Early warrant exercise
I dont see how any news can be released during this period of the discounted exercise of warrants period of Jan 16 to Feb 15. Looks like they would like to raise $6.5M during this period through this
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 29, 2023 8:27am
Early warrant exercise
i do not think this is good for the stock price. dan throws a monkey wrench into the stock price getting much traction if any ahead of jan/18th to mid febuary. When a warrant is exercised, the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 29, 2023 7:00am
New Press Release - Antibe Announces Early Warrant Exercise Incentive Program
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is pleased to announce an Early Warrant Exercise Incentive Program (“Early Warrant Exercise Program”) for its 6...
read article.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Dec 26, 2023 7:56pm
RE:(ATBPF) ATE on the us exchange
I'll say it like this ... The up and down movement in the price means nothing. The present price and the movements are not sending the price where it belongs ... because ... where it belongs is
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 26, 2023 4:18pm
(ATBPF) ATE on the us exchange
down 2.36 cents or 3.45%, was down as much as 4 cents. so i guess that means catch-up tomorrow for ATE?
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Dec 23, 2023 2:26pm
Merry Christmas All
What a great pivot it's been. New formulation, safer product and more control. Let's see where they take that in 2024 as we go to P2 for Acute and as they use DILIsym to plan out a
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 20, 2023 12:49pm
Also
most experts think a pullback in the (record high)market early in the newyear. a buying opportunity to get back in cheaper next year.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 20, 2023 12:44pm
Antibe selling off
today, no surprise the stock got ahead of itself. still a long way away untill start of P2 most likely not until march, and results not untill september 2024
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 14, 2023 8:01am
A Conversation With Antibe Therapeutics
15 Prince Arthur Ave. Toronto, ON, Canada, M5R 1B2 TSX:ATE OTCQX:ATBPF antibethera.com
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >